| Interlaboratory validation of small-scale solubility and dissolution measurements of poorly water-soluble drugs SBE Andersson, C Alvebratt, J Bevernage, D Bonneau, ... Journal of Pharmaceutical Sciences 105 (9), 2864-2872, 2016 | 48 | 2016 |
| An in vitro dissolution–digestion–permeation assay for the study of advanced drug delivery systems C Alvebratt, J Keemink, K Edueng, O Cheung, M Strømme, ... European Journal of Pharmaceutics and Biopharmaceutics 149, 21-29, 2020 | 26 | 2020 |
| Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers J Yang, C Alvebratt, P Zhang, TZG de la Torre, M Strømme, ... International Journal of Pharmaceutics 525 (1), 183-190, 2017 | 24 | 2017 |
| Controlled suspensions enable rapid determinations of intrinsic dissolution rate and apparent solubility of poorly water-soluble compounds SBE Andersson, C Alvebratt, CAS Bergström Pharmaceutical research 34, 1805-1816, 2017 | 22 | 2017 |
| Amorphous magnesium carbonate nanoparticles with strong stabilizing capability for amorphous ibuprofen J Yang, C Alvebratt, X Lu, CAS Bergström, M Strømme, K Welch International Journal of Pharmaceutics 548 (1), 515-521, 2018 | 11 | 2018 |
| A Modified In Situ Method to Determine Release from a Complex Drug Carrier in Particle-Rich Suspensions C Alvebratt, O Cheung, M Strømme, CAS Bergström AAPS PharmSciTech 19, 2859-2865, 2018 | 9 | 2018 |
| Zardán Gómez de la Torre T., Strømme M., Bergström CAS, Welch K. Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers J Yang, C Alvebratt, P Zhang Int. J. Pharm 525, 183-190, 2017 | 9 | 2017 |
| In vitro performance and chemical stability of lipid-based formulations encapsulated in a mesoporous magnesium carbonate carrier C Alvebratt, TJ Dening, M Åhlén, O Cheung, M Strømme, A Gogoll, ... Pharmaceutics 12 (5), 426, 2020 | 8 | 2020 |
| Advanced Methods for Evaluation of the Performance of Complex Drug Delivery System C Alvebratt Acta Universitatis Upsaliensis, 2021 | 2 | 2021 |
| Benefits of combining supersaturating and solubilizing formulations–Is two better than one? C Alvebratt, F Karlén, M Åhlén, K Edueng, I Dubbelboer, CAS Bergström International Journal of Pharmaceutics 663, 124437, 2024 | | 2024 |
| Two is better than one: benefits of combining supersaturating and solubilizing effects C Alvebratt, F Karlén, M Åhlén, K Edueng, IR Dubbelboer, CAS Bergström | | 2020 |
| Advanced methodologies to study in vitro digestion of a lipid-loaded mesoporous drug carrier C Alvebratt, T Denning, C Prestidge, C Bergström, M Strömme Preclinical Form and Formulation for Drug Discovery, Gordon Research …, 2019 | | 2019 |
| A new method that enables in situ measurement of drug release from complex carrier-mediated systems C Alvebratt, M Strömme, C Bergström 6th FIP Pharmaceutical Sciences World Congress 2017., 2017 | | 2017 |
| Synthesis of amorphous magnesium carbonate nanoparticles for biomedical applications J Yang, C Alvebratt, J Luo, C Bergström, M Strömme, K Welch Bioceramics 29-29th Symposium and Annual Meeting of ISCM 2017, 2017 | | 2017 |
| A Small Scale Method to Determine Release Rate from Complex Carrier-Mediated Systems C Alvebratt, E Petersson, M Strömme, CAS Bergström Book of Abstracts, 7, 2016 | | 2016 |
| Dissolution studies of solid formulations-Applicability of µDiss inmonitoring supersaturation, nucleation and crystallization behavior; Casestudy: Carrier-based formulation. C Alvebratt, E Petersson, M Strömme, C Bergström pION Fiber Optic Advanced Training Course. Uppsala, June 14-15, 2016., 2016 | | 2016 |
| Controlled suspensions as a method for small scale dissolution profiling of poorly soluble compounds S Andersson, C Alvebratt, J Gråsjö, C Bergström Book of Abstracts, 46, 0 | | |
| Controlled suspensions as a method for small scale dissolution of poorly water-soluble compounds S Andersson, C Alvebratt, J Gråsjö, C Bergström | | |
